IM Therapeutics Raises $10 Million Financing Co-Led by JDRF T1D Fund and Morningside Ventures
IM Therapeutics is a clinical stage company developing personalized therapies for autoimmune disease. On October 9th, they announced that...
Oct 17, 2019
top of page
Partnership Announcement
Recent Posts
Featured Posts
bottom of page